QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 iradimed-sees-q4-gaap-eps-043-047-vs-041-est

iRadimed (NASDAQ:IRMD) is looking for Q4 GAAP EPS of $0.43-$0.47 vs $0.41 analyst estimate..

 iradimed-sees-q4-adj-eps-047-051-vs-047-est-sees-sales-21400m-22400m-vs-20733m-est

iRadimed (NASDAQ:IRMD) is looking for Q4 Adj EPS of $0.47-$0.51 vs $0.47 analyst estimate. sees sales of $21.400 million-$22.40...

 iradimed-raises-fy2025-gaap-eps-guidance-from-160-170-to-168-172-vs-165-est

iRadimed (NASDAQ:IRMD) raises FY2025 GAAP EPS guidance from $1.60-$1.70 to $1.68-$1.72 vs $1.65 analyst estimate..

 iradimed-raises-fy2025-adj-eps-guidance-from-176-186-to-184-188-vs-182-est-raises-fy2025-sales-guidance-from-80000m-82500m-to-82500m-83500m-vs-81091m-est

iRadimed (NASDAQ:IRMD) raises FY2025 Adj EPS guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 analyst estimate. Raises FY2025 ...

 iradimed-q3-adj-eps-047-beats-046-estimate-sales-21202m-beat-20498m-estimate

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 3.3...

 preview-iradimeds-earnings
Preview: iRadimed's Earnings
10/31/2025 20:01:31

 earnings-preview-iradimed
Earnings Preview: iRadimed
07/31/2025 18:02:49

 iradimed-sees-q2-adj-eps-041-044-vs-043-est-sees-sales-19700m-19900m-vs-1981m-est

iRadimed (NASDAQ:IRMD) is looking for Q2 Adj EPS of $0.41-$0.44 vs $0.43 analyst estimate. sees sales of $19.700 million-$19.90...

 iradimed-affirms-fy2025-gaap-eps-guidance-of-155-165-vs-164-est

iRadimed (NASDAQ:IRMD) affirms FY2025 GAAP EPS guidance from $1.55-$1.65 to $1.55-$1.65 vs $1.64 analyst estimate..

 iradimed-sees-q2-gaap-eps-037-040-vs-041-est

iRadimed (NASDAQ:IRMD) is looking for Q2 GAAP EPS of $0.37-$0.40 vs $0.41 analyst estimate..

 iradimed-affirms-fy2025-adj-eps-guidance-of-171-181-vs-175-est-affirms-fy2025-sales-guidance-of-7800m-8200m-vs-7941m-est

iRadimed (NASDAQ:IRMD) affirms FY2025 Adj EPS guidance from $1.71-$1.81 to $1.71-$1.81 vs $1.75 analyst estimate. Affirms FY202...

 iradimed-q1-adj-eps-042-beats-041-estimate-sales-1951m-beat-1933m-estimate

iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.41 by 2.4...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION